Respiratory failure in systemic sclerosis.
COVID-19
Interstitial lung diseases
Respiratory insufficiency
Systemic sclerosis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
14 Oct 2023
14 Oct 2023
Historique:
received:
05
06
2023
accepted:
25
09
2023
medline:
15
10
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
aheadofprint
Résumé
Systemic sclerosis (SSc) can lead to dyspnea and respiratory failure through multiple mechanisms, making a precise diagnosis particularly challenging, especially amid the current COVID-19 pandemic. In this report, we present a case involving a 26-year-old female who had previously undiagnosed SSc. She experienced acute respiratory failure necessitating orotracheal intubation. Following an extensive evaluation, the patient exhibited skin thickening, kidney failure, thrombocytopenia, microangiopathic anemia, and an antinuclear antibody with a nuclear fine speckled pattern at a titer of 1:320. A diagnosis of SSc complicated by scleroderma renal crisis (SRC) was established. The patient's condition improved after undergoing hemodialysis, receiving an angiotensin-converting enzyme inhibitor, and undergoing cyclophosphamide treatment. Subsequently, she demonstrated sustained improvement during a follow-up period of 20 months.
Identifiants
pubmed: 37837449
doi: 10.1007/s00296-023-05482-4
pii: 10.1007/s00296-023-05482-4
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Volkmann ER, Andréasson K, Smith V (2022) Systemic sclerosis. Lancet. https://doi.org/10.1016/S0140-6736(22)01692-0
doi: 10.1016/S0140-6736(22)01692-0
pubmed: 36442487
pmcid: 9892343
Perelas A, Silver RM, Arrossi AV, Highland KB (2020) Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med 8:304–320. https://doi.org/10.1016/S2213-2600(19)30480-1
doi: 10.1016/S2213-2600(19)30480-1
pubmed: 32113575
Cole A, Ong VH, Denton CP (2022) Renal disease and systemic sclerosis: an update on scleroderma renal crisis. Clin Rev Allergy Immunol 1:1–14. https://doi.org/10.1007/S12016-022-08945-X/FIGURES/3
doi: 10.1007/S12016-022-08945-X/FIGURES/3
Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J et al (2020) Scleroderma renal crisis: risk factors for an increasingly rare organ complication. J Rheumatol 47:241–248. https://doi.org/10.3899/JRHEUM.180582
doi: 10.3899/JRHEUM.180582
pubmed: 30936287
Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E et al (2016) Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS ONE 11:e0163894. https://doi.org/10.1371/JOURNAL.PONE.0163894
doi: 10.1371/JOURNAL.PONE.0163894
pubmed: 27706206
pmcid: 5051961
Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE et al (2016) Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:103–109. https://doi.org/10.1136/ANNRHEUMDIS-2014-205295
doi: 10.1136/ANNRHEUMDIS-2014-205295
pubmed: 25165035
Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Rheumatology 37:15–20. https://doi.org/10.1093/RHEUMATOLOGY/37.1.15
doi: 10.1093/RHEUMATOLOGY/37.1.15
Steen VD, Medsger TA, Steen V (1998) Case–control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619. https://doi.org/10.1002/1529-0131
doi: 10.1002/1529-0131
pubmed: 9751093
Hachulla E, Agard C, Allanore Y, Avouac J, Bader-Meunier B, Belot A et al (2021) French recommendations for the management of systemic sclerosis. Orphanet J Rare Dis 16:1–61. https://doi.org/10.1186/S13023-021-01844-Y/FIGURES/5
doi: 10.1186/S13023-021-01844-Y/FIGURES/5
Hughes M, Kahaleh B, Denton CP, Mason JC, Matucci-Cerinic M (2021) ANCA in systemic sclerosis, when vasculitis overlaps with vasculopathy: a devastating combination of pathologies. Rheumatology 60:5509–5516. https://doi.org/10.1093/RHEUMATOLOGY/KEAB278
doi: 10.1093/RHEUMATOLOGY/KEAB278
pubmed: 33744916
Nagaraja V (2019) Management of scleroderma renal crisis. Curr Opin Rheumatol 31:223–230. https://doi.org/10.1097/BOR.0000000000000604
doi: 10.1097/BOR.0000000000000604
pubmed: 30870219
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815. https://doi.org/10.1136/ARD.2009.114264
doi: 10.1136/ARD.2009.114264
pubmed: 20551155
Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP et al (2020) Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J. https://doi.org/10.1183/13993003.02026-2019
doi: 10.1183/13993003.02026-2019
pubmed: 32079645
pmcid: 7236865
Juárez M, Misischia R, Alarcón GS (2003) Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum Dis Clin N Am 29:163–184. https://doi.org/10.1016/S0889-857X(02)00100-X
doi: 10.1016/S0889-857X(02)00100-X
Pagkopoulou E, Arvanitaki A, Daoussis D, Garyfallos A, Kitas G, Dimitroulas T (2019) Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheumatol Int 39(9):1507–1517. https://doi.org/10.1007/S00296-019-04371-Z
doi: 10.1007/S00296-019-04371-Z
pubmed: 31300848
Orlandi M, Landini N, Sambataro G, Nardi C, Tofani L, Bruni C et al (2022) The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19. Rheumatology 61:1600–1609. https://doi.org/10.1093/RHEUMATOLOGY/KEAB615
doi: 10.1093/RHEUMATOLOGY/KEAB615
pubmed: 34320649
Haque A, Kiely DG, Condliffe R, Kovacs G, Thompson AAR (2021) Pulmonary hypertension phenotypes in patients with systemic sclerosis. Eur Respir Rev. https://doi.org/10.1183/16000617.0053-2021
doi: 10.1183/16000617.0053-2021
pubmed: 34407977
pmcid: 9517999
Bruni C, Ross L (2021) Cardiac involvement in systemic sclerosis: getting to the heart of the matter. Best Pract Res Clin Rheumatol 35:101668. https://doi.org/10.1016/J.BERH.2021.101668
doi: 10.1016/J.BERH.2021.101668
pubmed: 33736950
Hanfi SH, Lalani TK, Saghir A, McIntosh LJ, Lo HS, Kotecha HM (2021) COVID-19 and its mimics: what the radiologist needs to know. J Thorac Imaging 36:W1-10. https://doi.org/10.1097/RTI.0000000000000554
doi: 10.1097/RTI.0000000000000554
pubmed: 32852419